NantKwest Says Investors Lack Standing For Some Claims
Investors who sued directors and officers of biopharmaceutical venture NantKwest Inc. and its high-profile CEO lack standing for their derivative claims and can't overcome director protections from damage awards, an attorney...To view the full article, register now.
Already a subscriber? Click here to view full article